Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Shares Outstanding (Diluted Average) (2020 - 2025)

Stemtech's Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $150.1 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) rose 30.97% year-over-year to $150.1 million; the TTM value through Sep 2025 reached $150.1 million, up 30.97%, while the annual FY2024 figure was $118.7 million, 42.2% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2025 was $150.1 million at Stemtech, up from $140.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $150.1 million in Q3 2025 and bottomed at $13.3 million in Q3 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $76.2 million (2023), against an average of $76.1 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) surged 279.07% in 2021 before it increased 21.6% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $35.3 million in 2021, then soared by 30.31% to $46.0 million in 2022, then soared by 81.4% to $83.5 million in 2023, then surged by 42.2% to $118.7 million in 2024, then rose by 26.46% to $150.1 million in 2025.
  • Per Business Quant, the three most recent readings for STEK's Shares Outstanding (Diluted Average) are $150.1 million (Q3 2025), $140.2 million (Q2 2025), and $118.7 million (Q1 2025).